文摘
In this report, the design and synthesis of a series of pyrimidine based adenosine A2A antagonists are described. The strategy and outcome of expanding SAR exploration to attenuate hERG and improve selectivity over A1 are discussed. Compound 33 exhibited excellent potency, selectivity over A1, and reduced hERG liability.